The clinical study involving 470 NAFLD patients with IF showed reductions in body weight, fat mass, and liver fat (hepatic steatosis) and alanine aminotransferase levels, all markers of liver damage. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.